SRI 63072

structure given in first source; PAF antagonist

Also Known As:

3-(2-((2-octadecylaminocarbonyloxymethyltetrahydro-2-furanylmethoxy)hydroxyphosphinyloxy)ethyl)thiazolium hydroxide inner salt-4-oxide; SRI-63-072

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Pulmonary Hypertension 11/01/1989 - "GBS-induced pulmonary hypertension could be reversed by SQ 29548; SRI 63072 did not affect PPA when administered to pigs with GBS-induced elevation in PPA. " 11/01/1989 - "Pretreatment with either platelet-activating factor antagonists SRI 63072 (3 mg/kg intravenous) or SRI 63441 (1 mg/kg) did not affect the pulmonary hypertension due to GBS infusion. "